Figure 1

Prostate histopathology.

β−dystroglycan immunohistochemistry in normal prostate (A–D), prostate cancer in situ showing varying degrees of dystroglycan loss (E–H) and in a bone metastasis sample (I), (J) where dystroglycan is re-expressed. Scale bars in all images represent 100 μm.